503 related articles for article (PubMed ID: 23721563)
21. Antibodies to post-translationally modified insulin as a novel biomarker for prediction of type 1 diabetes in children.
Strollo R; Vinci C; Napoli N; Pozzilli P; Ludvigsson J; Nissim A
Diabetologia; 2017 Aug; 60(8):1467-1474. PubMed ID: 28526919
[TBL] [Abstract][Full Text] [Related]
22. Associations between deduced first islet specific autoantibody with sex, age at diagnosis and genetic risk factors in young children with type 1 diabetes.
Ilonen J; Laine AP; Kiviniemi M; Härkönen T; Lempainen J; Knip M;
Pediatr Diabetes; 2022 Sep; 23(6):693-702. PubMed ID: 35403376
[TBL] [Abstract][Full Text] [Related]
23. Characterization of the humoral immune response to islet antigen 2 in children with newly diagnosed type 1 diabetes.
Mäkinen A; Härkönen T; Ilonen J; Knip M;
Eur J Endocrinol; 2008 Jul; 159(1):19-26. PubMed ID: 18573919
[TBL] [Abstract][Full Text] [Related]
24. Humoral beta-cell autoimmunity in relation to HLA-defined disease susceptibility in preclinical and clinical type 1 diabetes.
Knip M; Kukko M; Kulmala P; Veijola R; Simell O; Akerblom HK; Ilonen J
Am J Med Genet; 2002 May; 115(1):48-54. PubMed ID: 12116176
[TBL] [Abstract][Full Text] [Related]
25. Genetic variation at ERBB3/IKZF4 and sexual dimorphism in epitope spreading in single autoantibody-positive relatives.
Vandewalle J; Van der Auwera BJ; Amin H; Quartier E; Desouter AK; Tenoutasse S; Gillard P; De Block C; Keymeulen B; Gorus FK; Van de Casteele M;
Diabetologia; 2021 Nov; 64(11):2511-2516. PubMed ID: 34448034
[TBL] [Abstract][Full Text] [Related]
26. Neuropeptide Y is a minor autoantigen in newly diagnosed type 1 diabetes patients.
Skärstrand H; Vaziri-Sani F; Delli AJ; Törn C; Elding Larsson H; Ivarsson S; Agardh D; Lernmark Å;
Pediatr Diabetes; 2015 Dec; 16(8):621-8. PubMed ID: 25258030
[TBL] [Abstract][Full Text] [Related]
27. [Relationship between autoantibodies and HLA-DQ genotypes in patients with type 1 diabetes mellitus].
Wang JP; Zhang C; Lin J; Yuan Y; Zhou HF; Huang G; Zhou M; Zhou ZG
Zhonghua Yi Xue Za Zhi; 2007 Sep; 87(34):2380-4. PubMed ID: 18036312
[TBL] [Abstract][Full Text] [Related]
28. Early childhood CMV infection may decelerate the progression to clinical type 1 diabetes.
Ekman I; Vuorinen T; Knip M; Veijola R; Toppari J; Hyöty H; Kinnunen T; Ilonen J; Lempainen J
Pediatr Diabetes; 2019 Feb; 20(1):73-77. PubMed ID: 30338642
[TBL] [Abstract][Full Text] [Related]
29. Characteristics of Slow Progression to Type 1 Diabetes in Children With Increased HLA-Conferred Disease Risk.
Pöllänen PM; Lempainen J; Laine AP; Toppari J; Veijola R; Ilonen J; Siljander H; Knip M
J Clin Endocrinol Metab; 2019 Nov; 104(11):5585-5594. PubMed ID: 31314077
[TBL] [Abstract][Full Text] [Related]
30. No association of INS-VNTR genotype and IAA autoantibodies.
Pérez de Nanclares G; Bilbao JR; Castano L
Ann N Y Acad Sci; 2004 Dec; 1037():127-30. PubMed ID: 15699505
[TBL] [Abstract][Full Text] [Related]
31. The first signs of beta-cell autoimmunity appear in infancy in genetically susceptible children from the general population: the Finnish Type 1 Diabetes Prediction and Prevention Study.
Kimpimäki T; Kupila A; Hämäläinen AM; Kukko M; Kulmala P; Savola K; Simell T; Keskinen P; Ilonen J; Simell O; Knip M
J Clin Endocrinol Metab; 2001 Oct; 86(10):4782-8. PubMed ID: 11600541
[TBL] [Abstract][Full Text] [Related]
32. [Insulin autoantibodies and islet cell antibodies in recently appearing diabetes mellitus type I. Association with age of manifestation and HLA phenotype].
Ziegler AG; Rabl W; Albert E; Standl E
Dtsch Med Wochenschr; 1991 Nov; 116(46):1737-41. PubMed ID: 1935660
[TBL] [Abstract][Full Text] [Related]
33. Familial clustering of beta-cell autoimmunity in initially non-diabetic children.
Kukko M; Toivonen A; Kupila A; Korhonen S; Keskinen P; Veijola R; Virtanen SM; Ilonen J; Simell O; Knip M
Diabetes Metab Res Rev; 2006; 22(1):53-8. PubMed ID: 16100734
[TBL] [Abstract][Full Text] [Related]
34. First-degree relatives of persons with type 1 diabetes: insulin resistance and enterovirus infection are associated with different patterns of islet cell autoimmunity.
Cubas-Dueñas I; Cabrera-Rode E; Sarmiento L; Molina G; Fonseca M; Arranz C; Domínguez E; González P; Vera M; Díaz-Horta O
Acta Diabetol; 2013 Apr; 50(2):233-9. PubMed ID: 21604002
[TBL] [Abstract][Full Text] [Related]
35. The Giessen-Bad Oeynhausen family study: improved prediction of type I diabetes in a low incidence population of relatives using combinations of islet autoantibodies in a dual step model.
Jaeger C; Hatziagelaki E; Stroedter A; Becker F; Scherer S; Petzoldt R; Federlin K; Bretzel RG
Exp Clin Endocrinol Diabetes; 1999; 107(8):496-505. PubMed ID: 10612480
[TBL] [Abstract][Full Text] [Related]
36. Coxsackievirus B1 infections are associated with the initiation of insulin-driven autoimmunity that progresses to type 1 diabetes.
Sioofy-Khojine AB; Lehtonen J; Nurminen N; Laitinen OH; Oikarinen S; Huhtala H; Pakkanen O; Ruokoranta T; Hankaniemi MM; Toppari J; Vähä-Mäkilä M; Ilonen J; Veijola R; Knip M; Hyöty H
Diabetologia; 2018 May; 61(5):1193-1202. PubMed ID: 29404673
[TBL] [Abstract][Full Text] [Related]
37. Correlations between islet autoantibody specificity and the SLC30A8 genotype with HLA-DQB1 and metabolic control in new onset type 1 diabetes.
Brorsson C; Vaziri-Sani F; Bergholdt R; Eising S; Nilsson A; Svensson J; Lernmark Å; Pociot F;
Autoimmunity; 2011 Mar; 44(2):107-14. PubMed ID: 20836749
[TBL] [Abstract][Full Text] [Related]
38. Non-HLA gene effects on the disease process of type 1 diabetes: From HLA susceptibility to overt disease.
Lempainen J; Laine AP; Hammais A; Toppari J; Simell O; Veijola R; Knip M; Ilonen J
J Autoimmun; 2015 Jul; 61():45-53. PubMed ID: 26074154
[TBL] [Abstract][Full Text] [Related]
39. Longitudinal Pattern of First-Phase Insulin Response Is Associated With Genetic Variants Outside the Class II HLA Region in Children With Multiple Autoantibodies.
Koskinen MK; Mikk ML; Laine AP; Lempainen J; Löyttyniemi E; Vähäsalo P; Hekkala A; Härkönen T; Kiviniemi M; Simell O; Knip M; Veijola R; Ilonen J; Toppari J
Diabetes; 2020 Jan; 69(1):12-19. PubMed ID: 31591105
[TBL] [Abstract][Full Text] [Related]
40. Do glutamic acid decarboxylase antibodies improve the prediction of IDDM in first-degree relatives at risk for IDDM?
Schmidli RS; Colman PG; Harrison LC
J Autoimmun; 1994 Dec; 7(6):873-9. PubMed ID: 7888043
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
